Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
January 24, 2017
The article explains FDNA’s development of an app utilizing facial recognition software to identify genetic conditions more efficiently. This breakthrough technology helps detect various syndromes by analyzing patients’ facial features and comparing them with a vast database of genetic information. FDNA’s app leverages AI to recognize unique facial patterns associated with specific genetic disorders, significantly aiding healthcare professionals in early diagnosis and intervention. By integrating facial recognition with genetic data, FDNA’s decision support tool is a revolutionary advancement in medical diagnostics, offering a powerful resource for clinicians to improve patient outcomes in genetic condition management.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…